SCHEMBL25400308

SCHEMBL25400308

CC(C)CC(NC(=O)C1CC(CNC(=O)c2cccc(Oc3ccccc3)c2)=NO1)B(O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PSMB5 P28074 6/20 0.40
▸ PSMB8 P28062 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ ROCK2 O75116 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PPARG P37231 1/20 0.37
▸ PPARD Q03181 1/20 0.37
▸ PPARA Q07869 1/20 0.37
▸ RAF1 P04049 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25400303 1.00 LMNA (0.41) LMNAALDH1A1SMN1; SMN2RAB9APSMB5
SCHEMBL25400906 0.90 PSMB5 (0.46) PSMB5PSMB8CYP3A4
SCHEMBL25400915 0.90 PSMB5 (0.46) PSMB5PSMB8CYP3A4
SCHEMBL29846534 0.88 LMNA (0.43) LMNAALDH1A1SMN1; SMN2RAB9ACYP1A2
SCHEMBL25399866 0.86 CASP1 (0.43) RAB9APSMB5PSMB8TSHRNPC1
SCHEMBL25399858 0.86 CASP1 (0.43) RAB9APSMB5PSMB8TSHRNPC1
SCHEMBL24518166 0.83 RAB9A (0.46) LMNAALDH1A1SMN1; SMN2RAB9ACYP1A2
SCHEMBL25399206 0.81 NPSR1 (0.58) LMNAALDH1A1SMN1; SMN2RAB9ACYP1A2
SCHEMBL25399210 0.81 NPSR1 (0.58) LMNAALDH1A1SMN1; SMN2RAB9ACYP1A2
SCHEMBL29847201 0.80 NPC1 (0.51) LMNAALDH1A1SMN1; SMN2RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 LMNA 151/4885ALDH1A1 3621/4885SMN1; SMN2 777/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 LMNA 1548/4885ALDH1A1 2005/4885SMN1; SMN2 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback